Roles of TGF-β family signaling in stem cell renewal and differentiation

被引:333
作者
Watabe, Tetsuro [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan
关键词
embryonic stem cells; somatic stem cells; cancer stem cells; BMP; Wnt; ENDOTHELIAL-CELLS; SELF-RENEWAL; MESENCHYMAL TRANSITION; NEURAL CREST; BONE-MARROW; DEFINITIVE ENDODERM; MYELOID-LEUKEMIA; COMMON PRECURSOR; DIVERGING POINT; HAIR-FOLLICLES;
D O I
10.1038/cr.2008.323
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor (TGF)-beta s and their family members, including bone morphogenetic proteins (BMPs), Nodal and activins, have been implicated in the development and maintenance of various organs, in which stem cells play important roles. Stem cells are characterized by their ability to self-renew and to generate differentiated cells of a particular tissue, and are classified into embryonic and somatic stem cells. Embryonic stem (ES) cells self-renew indefinitely and contribute to derivatives of all three primary germ layers. In contrast, somatic stem cells, which can be identified in various adult organs, exhibit limited abilities for self-renewal and differentiation in most cases. The multi-lineage differentiation capacity of ES cells and somatic stem cells has opened possibilities for cell replacement therapies for genetic, malignant and degenerative diseases. In order to utilize stem cells for therapeutic applications, it is essential to understand the extrinsic and intrinsic factors regulating self-renewal and differentiation of stem cells. More recently, induced pluripotent stem (iPS) cells have been generated from mouse and human fibroblasts that resemble ES cells via ectopic expression of four transcription factors. iPS cells may have an advantage in regenerative medicine, since they overcome the immunogenicity and ethical controversy of ES cells. Moreover, recent studies have highlighted the involvement of cancer stem cells during the formation and progression of various types of cancers, including leukemia, glioma, and breast cancer. Here, we illustrate the roles of TGF-beta family members in the maintenance and differentiation of ES cells, somatic stem cells, and cancer stem cells.
引用
收藏
页码:103 / 115
页数:13
相关论文
共 114 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   The hair cycle [J].
Alonso, L ;
Fuchs, E .
JOURNAL OF CELL SCIENCE, 2006, 119 (03) :391-393
[3]   For the long run: Maintaining germinal niches in the adult brain [J].
Alvarez-Buylla, A ;
Lim, DA .
NEURON, 2004, 41 (05) :683-686
[4]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[5]   Identification of stem cells in small intestine and colon by marker gene Lgr5 [J].
Barker, Nick ;
van Es, Johan H. ;
Kuipers, Jeroen ;
Kujala, Pekka ;
van den Born, Maaike ;
Cozijnsen, Miranda ;
Haegebarth, Andrea ;
Korving, Jeroen ;
Begthel, Harry ;
Peters, Peter J. ;
Clevers, Hans .
NATURE, 2007, 449 (7165) :1003-U1
[6]  
BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733
[7]   Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells [J].
Boland, GM ;
Perkins, G ;
Hall, DJ ;
Tuan, RS .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 93 (06) :1210-1230
[8]   Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation [J].
Brandenberger, R ;
Wei, H ;
Zhang, S ;
Lei, S ;
Murage, J ;
Fisk, GJ ;
Li, Y ;
Xu, CH ;
Fang, R ;
Guegler, K ;
Rao, MS ;
Mandalam, R ;
Lebkowski, J ;
Stanton, LW .
NATURE BIOTECHNOLOGY, 2004, 22 (06) :707-716
[9]   Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5) [J].
Callahan, JF ;
Burgess, JL ;
Fornwald, JA ;
Gaster, LM ;
Harling, JD ;
Harrington, FP ;
Heer, J ;
Kwon, C ;
Lehr, R ;
Mathur, A ;
Olson, BA ;
Weinstock, J ;
Laping, NJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (05) :999-1001
[10]  
Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67